![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-ab2aabb4df57278837cd1e845afb0fc2e3517d28fac3edfa7c3272b958d59dc4.jpg)
Tocilizumab for Neuromyelitis Optica Spectrum Disorder
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.